Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pacbio
    Member
    • Sep 2011
    • 91

    #1

    3/8 Webinar: Sequencing SVs for Disease Gene Discovery & Population Genetics

    Join us to learn how human geneticists are adding low-coverage, long-read whole genome sequencing to their study designs to fully power genetic variant discovery and ultimately identify disease-causing variants and genes.

    During this webcast you will learn about:
    • Methods for calling and visualizing structural variants from low-coverage, long-read sequencing of human genomes
    • Optimal study designs to fully power SV detection for gene discovery in rare and Mendelian diseases
    • Cost-effective population genetics study designs for common SV reporting down to < 1% allele frequency
    • Case studies demonstrating genetic discovery in rare Mendelian disease subjects


    Speakers:

    Alexander Hoischen Ph.D., Radboud University Medical Center
    Aaron Wenger Ph.D., Principal Scientist, PacBio

    Watch Recording
    Last edited by pacbio; 03-19-2018, 09:44 AM. Reason: Live webinar has past, now linking to recording

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...